GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
X

Xiamen Amoytop Biotech Co 688278.SS · CNY

Health Care · Shanghai · 🇨🇳 China

Compare

43.82

-2.82%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Analyst ratings

6 analysts, 1 Mar 2026. The analysts' own views, not ours.

  • 2Strong buy
  • 3Buy
  • 1Hold
  • 0Sell
  • 0Strong sell

Price targets

Brokers' own targets, 21 Feb 2026. Not our view.

Average target 94.59

Low
93.67
Average
94.59
Median
94.59
High
97.38

Forecasts

Analyst averages for the fiscal years ahead

FY2026FY2027FY2028
RevenueCN¥4.59bnCN¥5.55bnCN¥6.61bn
Revenue, highestCN¥4.82bnCN¥5.96bnCN¥7.12bn
Revenue, lowestCN¥4.44bnCN¥5.33bnCN¥6.17bn
Earnings per share2.993.674.42
Earnings per share, highest3.183.905.11
Earnings per share, lowest2.863.513.96
Analysts144

Earnings against forecasts

Earnings per share by fiscal quarter

Q3 2026Q2 2026
Forecast0.650.65
Reported0.000.77
Difference-99.7%+18.5%

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

6 / 10

Revenue growth 0.0% a year over 10 years. Return on equity 34.5%.

Model fair value

80.89

From earnings 80.89, from revenue 85.97.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.